Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

Kyoko Fuse, MD, Takayuki Katagiri, MD, Yasuhiko Shibasaki, MD PhD, Tomoyuki Tanaka, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD, Tatsuo Furukawa, MD PhD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Takashi Ushiki, MD PhD

Blood (2016) 128 (22): 2297.

https://doi.org/10.1182/blood.V128.22.2297.2297

Published: 2016

Journal Articles

Log Reduction Levels of WT1 mRNA Expression in BM after Chemotherapies Are Predictive Markers of Good Prognosis in AML Patients Achieved CR after Induction Therapy

Yasuhiko Shibasaki, MD PhD, Yoshinobu Seki, MD PhD, Tomoyuki Tanaka, MD, Syukuko Miyakoshi, MD, Kyoko Fuse, MD, Takashi Kozakai, MD, Hironori Kobayashi, MD PhD, Takashi Ushiki, MD PhD, Takashi Abe, MD PhD, Toshio Yano, MD PhD, Masato Moriyama, MD PhD, Takashi Kuroha, MD PhD, Noriatsu Isahai, MD PhD, Jun Takizawa, MD, PhD, Miwako Narita, MD PhD, Satoru Koyama, MD PhD, Tatsuo Furukawa, MD PhD, Hirohito Sone, MDPhD, Masayoshi Masuko, MD PhD

Blood (2014) 124 (21): 2334.

https://doi.org/10.1182/blood.V124.21.2334.2334

Published: 2014

Journal Articles

Early Responses At 3 Months and 12 Months After Starting Imatinib As Predictive Factors For The Achievement Of Deep MR In Japanese CML Patients

Masayoshi Masuko, MD, PhD, Tatsuo Furukawa, MD, PhD, Tadashi Koike, MD, Kazue Takai, MD, Koichi Nagai, MD, Kenji Kishi, MD, PhD, Yoshinobu Seki, MD, Hoyu Takahashi, MD, PhD, Sadao Aoki, MD, PhD, Takashi Kozakai, MD, Yasuhiko Shibasaki, MD, Takashi Ushiki, MD, Ken Toba, MD, PhD, Miwako Narita, MD, PhD, Masuhiro Takahashi, MD, PhD, Hirohito Sone, MD, PhD, Akira Shibata, MD

Blood (2013) 122 (21): 2744.

https://doi.org/10.1182/blood.V122.21.2744.2744

Published: 2013

Journal Articles

Clinical Factors Predicting the Response of Acute Graft-Versus-Host Disease to Corticosteroid Therapy.

Makoto Murata, MD, PhD, Hideki Nakasone, MD, Junya Kanda, MD, PhD, Takahiko Nakane, MD, PhD, Tatsuo Furukawa, MD, PhD, Takahiro Fukuda, MD, PhD, Shuichi Taniguchi, MD, PhD, Takehiko Mori, M.D., Tetsuya Eto, MD, PhD, Yasuo Morishima, M.D., Tokiko Nagamura-Inoue, MD, PhD., Hiromasa Yabe, Yoshiko Atsuta, MD, PhD, Hisashi Sakamaki, MD, Ritsuro Suzuki, M.D.

Blood (2012) 120 (21): 3046.

https://doi.org/10.1182/blood.V120.21.3046.3046

Published: 2012

Journal Articles

Correlation Between Imatinib Trough Concentration and Long-Term Tolerability in CML Patients

Masayoshi Masuko, MD, PhD, Tatsuo Furukawa, MD, PhD, Toyoyuki Tanaka, MD, Syukuko Miyakoshi, MD, Takashi Kozakai, MD, Kyoko Fuse, MD, Yasuhiko Shibasaki, MD, Kazue Takai, MD, Yoshinobu Seki, MD, Masashi Kobayashi, MD, Koichi Nagai, MD, Hoyu Takahashi, MD, Kenji Kishi, MD, PhD, Miwako Narita, MD, PhD, Masuhiro Takahashi, Tadashi Koike, MD, Akira Shibata, MD

Blood (2012) 120 (21): 3751.

https://doi.org/10.1182/blood.V120.21.3751.3751

Published: 2012

Journal Articles

The Useful Individualized Assessment of Immunosuppressive Therapy with Cyclosporine A (CsA) after Allogeneic Stem Cell Transplantation by Simultaneous Analyses of Cytokine Production among CD4+ T Cells and Blood CsA Levels.

Nobuhiro Tsukada, MD, PhD, Tatsuo Furukawa, MD, PhD, Hiromi Ito, Noriko Izumi, MD, Akihito Momoi, MD, Kiyoshi Okazuka, MD, Keiichiro Honma, MD, Masayoshi Masuko, MD, PhD, Shigeo Hashimoto, MD, PhD, Sadao Aoki, MD, PhD, Yoshifusa Aizawa, MD, PhD

Blood (2004) 104 (11): 5076.

https://doi.org/10.1182/blood.V104.11.5076.5076

Published: 2004

NARROW

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

Log Reduction Levels of WT1 mRNA Expression in BM after Chemotherapies Are Predictive Markers of Good Prognosis in AML Patients Achieved CR after Induction Therapy

Early Responses At 3 Months and 12 Months After Starting Imatinib As Predictive Factors For The Achievement Of Deep MR In Japanese CML Patients

Clinical Factors Predicting the Response of Acute Graft-Versus-Host Disease to Corticosteroid Therapy.

Correlation Between Imatinib Trough Concentration and Long-Term Tolerability in CML Patients

The Useful Individualized Assessment of Immunosuppressive Therapy with Cyclosporine A (CsA) after Allogeneic Stem Cell Transplantation by Simultaneous Analyses of Cytokine Production among CD4+ T Cells and Blood CsA Levels.

Email alerts

ASH Publications

American Society of Hematology

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

Log Reduction Levels of WT1 mRNA Expression in BM after Chemotherapies Are Predictive Markers of Good Prognosis in AML Patients Achieved CR after Induction Therapy

Early Responses At 3 Months and 12 Months After Starting Imatinib As Predictive Factors For The Achievement Of Deep MR In Japanese CML Patients

Clinical Factors Predicting the Response of Acute Graft-Versus-Host Disease to Corticosteroid Therapy.

Correlation Between Imatinib Trough Concentration and Long-Term Tolerability in CML Patients

The Useful Individualized Assessment of Immunosuppressive Therapy with Cyclosporine A (CsA) after Allogeneic Stem Cell Transplantation by Simultaneous Analyses of Cytokine Production among CD4+ T Cells and Blood CsA Levels.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only